Thermo Fisher Scientific Inc. has completed its acquisition of Olink Holding AB, a provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion. Olink will become part of Thermo Fisher's Life Sciences Solutions segment.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,